[1] [1] DIB-HAJJ S D, YANG Y, BLACK J A, et al. The Na(V)1.7 sodium channel: from molecule to man ［J］. Nature Reviews Neuroscience, 2013, 14(1): 49-62.

[2] [2] DE LERA RUIZ M, KRAUS R L. Voltage-gated sodium channels: structure, function, pharmacology, and clinical indications ［J］. Journal of Medicinal Chemistry, 2015, 58(18): 7093-7118.

[4] [4] COX J J, REIMANN F, NICHOLAS A K, et al. An SCN9A channelopathy causes congenital inability to experience pain ［J］. Nature, 2006, 444(7121): 894-898.

[5] [5] ESTACION M, DIB-HAJJ S D, BENKE P J, et al. Nav1.7 gain-of-function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders ［J］. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience, 2008, 28(43): 11079-11088.

[6] [6] GINGRAS J, SMITH S, MATSON D J, et al. Global Nav1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain ［J］. PLoS One, 2014, 9(9): e105895.

[7] [7] GOLDBERG Y P, MACFARLANE J, MACDONALD M L, et al. Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations ［J］. Clinical Genetics, 2007, 71(4): 311-319.

[8] [8] SUTER M R, BHUIYAN Z A, LAEDERMANN C J, et al. p.L1612P, a novel voltage-gated sodium channel Nav1.7 mutation inducing a cold sensitive paroxysmal extreme pain disorder ［J］. Anesthesiology, 2015, 122(2): 414-423.

[9] [9] YANG Y, HUANG J, MIS M A, et al. Nav1.7-A1632G mutation from a family withinherited erythromelalgia: enhanced firing of dorsal root ganglia neurons evoked by thermal stimuli ［J］. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience, 2016, 36(28): 7511-7522.

[10] [10] YANG Y, WANG Y, LI S, et al. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia ［J］. Journal of Medical Genetics, 2004, 41(3): 171-174.

[11] [11] LANGENEGGER N, NENTWIG W, KUHN-NENTWIG L. Spider venom: components, modes of action, and novel strategies in transcriptomic and proteomic analyses ［J］. Toxins, 2019, 11(10): 611.

[12] [12] DONGOL Y, CARDOSO F C, LEWIS R J. Spider knottin pharmacology at voltage-gated sodium channels and their potential to modulate pain pathways ［J］. Toxins, 2019, 11(11): 626.

[13] [13] WU T, WANG M, WU W, et al. Spider venom peptides as potential drug candidates due to their anticancer and antinociceptive activities ［J］. The Journal of Venomous Animals and Toxins Including Tropical Diseases, 2019, 25: e146318.

[14] [14] CATTERALL W A, CESTèLE S, YAROV-YAROVOY V, et al. Voltage-gated ion channels and gating modifier toxins ［J］. Toxicon: Official Journal of the International Society on Toxinology, 2007, 49(2): 124-141.

[15] [15] LIANG S. An overview of peptide toxins from the venom of the Chinese bird spider Selenocosmia huwena Wang ［=Ornithoctonus huwena(Wang)］ ［J］. Toxicon: Official Journal of the International Society on Toxinology, 2004, 43(5): 575-585.

[16] [16] KING G F, GENTZ M C, ESCOUBAS P, et al. A rational nomenclature for naming peptide toxins from spiders and other venomous animals ［J］. Toxicon: Official Journal of the International Society on Toxinology, 2008, 52(2): 264-276.

[17] [17] ZHANG Y, TACHTSIDIS G, SCHOB C, et al. KCND2 variants associated with global developmental delay differentially impair Kv4.2 channel gating ［J］. Human Molecular Genetics, 2021, 30(23): 2300-2314.

[18] [18] CHOW C Y, CRISTOFORI-ARMSTRONG B, UNDHEIM E A, et al. Three peptide modulators of the human voltage-gated sodium channel 1.7, an important analgesic target, from the venom of an Australian Tarantula ［J］. Toxins, 2015, 7(7): 2494-2513.

[19] [19] CARDOSO F C, DEKAN Z, ROSENGREN K J, et al. Identification and characterization of ProTx-III ［μ-TRTX-Tp1a］, a new voltage-gated sodium channel inhibitor from venom of the tarantula Thrixopelma pruriens ［J］. Molecular Pharmacology, 2015, 88(2): 291-303.

[20] [20] REVELL J D, LUND P E, LINLEY J E, et al. Potency optimization of Huwentoxin-IV on hNav1.7: a neurotoxin TTX-S sodium-channel antagonist from the venom of the Chinese bird-eating spider Selenocosmia huwena ［J］. Peptides, 2013, 44: 40-46.

[21] [21] XIAO Y, BINGHAM J P, ZHU W, et al. Tarantula huwentoxin-IV inhibits neuronal sodium channels by binding to receptor site 4 and trapping the domain ii voltage sensor in the closed configuration ［J］. The Journal of Biological Chemistry, 2008, 283(40): 27300-27313.

[22] [22] LIU Z, CAI T, ZHU Q, et al. Structure and function of hainantoxin-III, a selective antagonist of neuronal tetrodotoxin-sensitive voltage-gated sodium channels isolated from the Chinese bird spider Ornithoctonus hainana ［J］. The Journal of Biological Chemistry, 2013, 288(28): 20392-20403.